|
|
|
Insider
Information: |
Kirk Randal J |
Relationship: |
10% Owner |
City: |
Radford |
State: |
VA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
3,684,697 |
|
Indirect Shares
|
67,796,291 |
|
|
Direct
Value |
$162,038,028 |
|
|
Indirect Value
|
$374,282,250 |
|
|
Total
Shares |
71,480,988 |
|
|
Total
Value |
$536,320,277 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
14
|
0
|
Stock
price went up :
|
6
|
0
|
Stock
price went down : |
8
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
46.5%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Clinical Data Inc |
CLDA |
Director, 10% Owner |
2011-04-12 |
0 |
2011-04-12 |
0 |
Premium* |
|
Halozyme Therapeutics Inc |
HALO |
10% Owner |
2018-08-28 |
3,562,388 |
2018-08-28 |
6,629,464 |
Premium* |
|
Precipio Inc |
PRPO |
10% Owner |
2012-02-03 |
0 |
2018-08-28 |
27,151 |
Premium* |
|
Precigen Inc |
PGEN |
|
|
0 |
2024-05-02 |
51,557,665 |
Premium* |
|
Alaunos Therapeutics |
TCRT |
Director, 10% Owner |
2015-12-31 |
122,309 |
2015-12-31 |
9,570,094 |
Premium* |
|
Aquabounty Technologies, Inc. |
AQB |
10% Owner |
2020-02-13 |
0 |
2020-12-17 |
11,917 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
271 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 11
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-09-15 |
4 |
B |
$2.50 |
$256,250 |
I/I |
102,500 |
780,800 |
1.5 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-12-04 |
4 |
B |
$2.86 |
$32,890 |
I/I |
11,500 |
792,300 |
1.5 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-12-05 |
4 |
B |
$2.84 |
$151,940 |
I/I |
53,500 |
845,800 |
1.5 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-12-07 |
4 |
B |
$5.55 |
$1,865,910 |
I/I |
336,200 |
1,182,000 |
1.5 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-12-11 |
4 |
B |
$6.16 |
$492,800 |
I/I |
80,000 |
1,262,000 |
1.5 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2007-03-13 |
4 |
B |
$7.93 |
$365,414 |
I/I |
46,080 |
1,308,080 |
1.5 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2007-03-14 |
4 |
B |
$7.91 |
$238,882 |
I/I |
30,200 |
522,460 |
1.5 |
- |
|
PRPO |
Precipio Inc |
10% Owner |
|
2012-02-03 |
4 |
A |
$0.00 |
$0 |
I/I |
3,000,000 |
649,181 |
0 |
- |
|
PRPO |
Precipio Inc |
10% Owner |
|
2013-01-25 |
4 |
B |
$0.00 |
$0 |
I/I |
6,000,000 |
1,849,181 |
1.42 |
- |
|
PRPO |
Precipio Inc |
10% Owner |
|
2016-01-06 |
4 |
B |
$1.00 |
$4,474,825 |
I/I |
4,474,825 |
894,613 |
1.5 |
- |
|
PRPO |
Precipio Inc |
10% Owner |
|
2016-01-06 |
4 |
A |
$0.00 |
$0 |
I/I |
2,305,354 |
577,319 |
0 |
- |
|
PRPO |
Precipio Inc |
10% Owner |
|
2017-06-08 |
4 |
S |
$1.00 |
$1,975,000 |
I/I |
(1,975,000) |
786,613 |
0 |
- |
|
PRPO |
Precipio Inc |
10% Owner |
|
2017-06-29 |
4 |
A |
$0.00 |
$5,289,450 |
I/I |
359,785 |
27,651 |
0 |
- |
|
PRPO |
Precipio Inc |
10% Owner |
|
2017-08-28 |
4 |
A |
$0.00 |
$0 |
I/I |
813,482 |
271,824 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-06-27 |
4 |
S |
$17.34 |
$927,777 |
I/I |
(53,505) |
3,945,650 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-06-28 |
4 |
S |
$16.99 |
$2,181,261 |
I/I |
(128,385) |
3,869,359 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-06-29 |
4 |
S |
$16.97 |
$2,077,654 |
I/I |
(122,431) |
3,796,606 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-07-25 |
4 |
S |
$17.32 |
$1,799,548 |
I/I |
(103,900) |
3,734,865 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-07-26 |
4 |
S |
$17.30 |
$2,595,000 |
I/I |
(150,000) |
3,645,729 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-07-27 |
4 |
S |
$16.90 |
$826,866 |
I/I |
(48,927) |
3,616,655 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-08-08 |
4 |
S |
$17.52 |
$2,570,499 |
I/I |
(146,718) |
3,529,470 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-08-09 |
4 |
S |
$17.48 |
$3,900,260 |
I/I |
(223,127) |
3,396,879 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-08-10 |
4 |
S |
$17.08 |
$3,466,540 |
I/I |
(202,959) |
3,276,273 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-08-14 |
4 |
S |
$17.36 |
$5,262,996 |
I/I |
(303,168) |
3,096,119 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-08-15 |
4 |
S |
$17.15 |
$1,569,928 |
I/I |
(91,541) |
3,041,722 |
0 |
- |
|
271 Records found
|
|
Page 2 of 11 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|